Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CIGX - Three new links to sites from the Roskamp Institute

|Includes: Rock Creek Pharmaceuticals, Inc. (RCPI)

Alert: Just recently received and havent seen elsewhere

Three links from the Roskamp Institute to new sites that provides easier access to the Roskamp research on anatabine

The Roskamp Institute has just created some new websites that address their ongoing research on Alzheimer’s and anatabine. The newly constructed sites specifically reference and collate the mounting anatabine data in a more accessible and comprehensive way allowing for easier orientation to the relevant archived data.

The sites allow easier reference to older more difficult to access Roskamp / Mullan research that was published, for example in the Archives of Neurology, the peer reviewed journal Amyloid and The European Journal of Pharmacology. Several Roskamp videos are also available.

In addition the new sites allow accessibility to Roskamsp /Mullan’s latest postings, a blog and notification of upcoming events.

The new sites also allow for registration to the Alzheimer Mullan Research Notes.

Inflammaging specific:   

http://inflammaging.mullanalzheimer.com

General Blogs and articles:

Http://www.mullanalzheimer.com

Http://www.mullanalzheimer.info

 

The Roskamp Institute is devoted to understanding causes and finding cures for neuropsychiatric and neurodegenerative disorders and addictions. The Institute utilizes a broad range of scientific approaches to understanding the causes of and potential therapies for these disorders with an emphasis on Alzheimer’s disease. For more information, please call (941)752-2949